East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Enalapril Maleate Oral Solution, 1 mg/mL. Aurobindo Pharma’s Enalapril Maleate Oral Solution, are an AB-rated generic equivalent to the reference listed drug (RLD), Epaned® Oral Solution manufactured by Azurity Pharmaceuticals, Inc.

Enalapril Maleate Oral Solution are indicated for the treatment of:

• Hypertension
• Symptomatic heart failure
• Asymptomatic left ventricular dysfunction.